Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lee Mosley

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Cancer Research|September 6, 2005
Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapyJanina Baranowska-Kortylewicz, Michio Abe, Kristian Pietras, et al.
Journal of Nanomedicine & Nanotechnology|January 31, 2012
Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's DiseaseYuling Zhao, Matthew J Haney, Vivek Mahajan, et al.
Journal of Neurochemistry|June 8, 2010
Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesLisa M Kosloski, Duy M Ha, Jessica A L Hutter, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's diseaseAnamitra Ghosh, Avik Roy, Xiaojuan Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2010
Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophagesAri S Nowacek, Shantanu Balkundi, JoEllyn McMillan, et al.
Nanomedicine (London, England)|April 17, 2010
Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's diseaseAnna M Brynskikh, Yuling Zhao, R Lee Mosley, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 23, 2016
Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's DiseaseKatherine E Olson, Aditya N Bade, Charles R Schutt, et al.
Current HIV Research|April 1, 2004
Advances in neuroimaging for HIV-1 associated neurological dysfunction: clues to the diagnosis, pathogenesis and therapeutic monitoringMichael D Boska, R Lee Mosley, Mehmood Nawab, et al.
Plos One|February 3, 2009
Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticlesArnaud Beduneau, Zhiya Ma, Cassi B Grotepas, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 4, 2015
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseasesHoward E Gendelman, Vellareddy Anantharam, Tatiana Bronich, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Cancer Research|September 6, 2005
Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapyJanina Baranowska-Kortylewicz, Michio Abe, Kristian Pietras, et al.
Journal of Nanomedicine & Nanotechnology|January 31, 2012
Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's DiseaseYuling Zhao, Matthew J Haney, Vivek Mahajan, et al.
Journal of Neurochemistry|June 8, 2010
Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesLisa M Kosloski, Duy M Ha, Jessica A L Hutter, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's diseaseAnamitra Ghosh, Avik Roy, Xiaojuan Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2010
Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophagesAri S Nowacek, Shantanu Balkundi, JoEllyn McMillan, et al.
Nanomedicine (London, England)|April 17, 2010
Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's diseaseAnna M Brynskikh, Yuling Zhao, R Lee Mosley, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 23, 2016
Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's DiseaseKatherine E Olson, Aditya N Bade, Charles R Schutt, et al.
Current HIV Research|April 1, 2004
Advances in neuroimaging for HIV-1 associated neurological dysfunction: clues to the diagnosis, pathogenesis and therapeutic monitoringMichael D Boska, R Lee Mosley, Mehmood Nawab, et al.
Plos One|February 3, 2009
Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticlesArnaud Beduneau, Zhiya Ma, Cassi B Grotepas, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 4, 2015
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseasesHoward E Gendelman, Vellareddy Anantharam, Tatiana Bronich, et al.
Pageof 11